Drugs / Viral Specific T-cells (VSTs)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04406064 | Jan 2021 → Jun 2024 | viral infectious disease | Children's Hospital Medical Center, Cincinnati | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03883906 | Mar 2019 → Oct 2020 | disease related to hematopoietic stem cell transplant, viral infectious disease | Children's Hospital Medical Center, Cincinnati | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Viral Specific T-cells (VSTs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04406064 ↗ |
| Known as | VSTs | “VSTs are cells specially designed to fight viral infections that may happen after a stem cell transplant (SCT).” NCT03883906 ↗ |
| Modality | Cell therapy | “VSTs are cells specially designed to fight viral infections that may happen after a stem cell transplant (SCT).” NCT03883906 ↗ |